Medisca recalls swapped drugs

Share this article:

FDA testing revealed that lots of Medisca's L-citrulline did not contain the drug, but did test positive for medication used to treat vertigo.

The regulator announced the testing results Monday, three days after notifying healthcare professionals of adverse events associated with some of Medisca's medication. L-citrulline is used to treat rare genetic disorders usually found in children.

Medisca has recalled eight lots of the drug.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.